Comment on Bloomberg website from a few days ago from GSK Spokesman in phone interview from London: "Glaxo’s Rea said today that the drugmaker is producing Relenza at “full capacity.” Glaxo is “urgently assessing mechanisms to increase production of Relenza,” the company said in a statement." Eventually BTA will bank the royalty cheque from this full capacity. BTA story still has some legs. Regards Buffett PS Suspect full capacity production of Relenza can top $33.2m for a quarter!
BTA Price at posting:
$1.38 Sentiment: None Disclosure: Held